Published in
Springer, Acta Neuropathologica, 6(142), p. 1065-1069, 2021
DOI: 10.1007/s00401-021-02369-1
Links
Tools
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Journal article published in 2021 by
Philipp Sievers 
,
Damian Stichel,
Martin Sill,
Daniel Schrimpf,
Dominik Sturm,
Florian Selt,
Jonas Ecker,
Daniel Kazdal,
Evelina Miele,
Mariëtte E. G. Kranendonk,
Kranendonk Meg,
Tops Bbj,
Bastiaan B. J. Tops,
Patricia Kohlhof-Meinecke,
Rudi Beschorner
and other authors.
,
Damian Stichel,
Martin Sill,
Daniel Schrimpf,
Dominik Sturm,
Florian Selt,
Jonas Ecker,
Daniel Kazdal,
Evelina Miele,
Mariëtte E. G. Kranendonk,
Kranendonk Meg,
Tops Bbj,
Bastiaan B. J. Tops,
Patricia Kohlhof-Meinecke,
Rudi Beschorner
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 